Variation of lipids and lipoproteins in premenopausal women compared with men and postmenopausal women. DELTA (Dietary Effects on Lipoproteins and Thrombogenic Activity) Investigators
- PMID: 11016887
- DOI: 10.1053/meta.2000.8603
Variation of lipids and lipoproteins in premenopausal women compared with men and postmenopausal women. DELTA (Dietary Effects on Lipoproteins and Thrombogenic Activity) Investigators
Abstract
Numerous studies have reported cyclic fluctuations in lipids and lipoproteins as a function of the phase of the menstrual cycle. However, the reported patterns are quite variable and have led to an unclear picture of the influence of the menstrual cycle on the variability of lipids, and hence of the role of the menstrual cycle phase in the interpretation of serum lipids for premenopausal women. As part of the DELTA Study (Dietary Effects on Lipoproteins and Thrombogenic Activity), we evaluated the cyclic variation of circulating lipids and lipoproteins in 39 premenopausal women and compared intraindividual variances in these women, 18 postmenopausal women, and 46 men under conditions of tight dietary control. Cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, triglyceride, apolipoproteins A-1 (apo A-1) and B-100 (apo B-100), and lipoprotein (a) [Lp(a)] all demonstrated cycling in the premenopausal women. However, the observed cycling accounts for only a small fraction of the total biologic variability of lipids in premenopausal women. The magnitude of total intraindividual variability based on coefficient of variation (CV) for these lipids in premenopausal women (CV, 4% to 8.1%) was similar to that found for men (CV, 4.3% to 9.1%) and for postmenopausal women (CV, 3.7% to 6.7%). These results suggest that protocols for screening and monitoring of serum lipids in premenopausal women need not differ from those used for men or postmenopausal women.
Similar articles
-
Cyclic changes in lipoprotein and apolipoprotein levels during the menstrual cycle in healthy premenopausal women on a controlled diet.J Clin Endocrinol Metab. 1996 Oct;81(10):3599-603. doi: 10.1210/jcem.81.10.8855808. J Clin Endocrinol Metab. 1996. PMID: 8855808
-
Effect of estrogen-progestin replacement therapy on plasma lipids and lipoproteins in postmenopausal women.Endocr Res. 2000 May;26(2):263-73. doi: 10.3109/07435800009066166. Endocr Res. 2000. PMID: 10921452 Clinical Trial.
-
Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women.Am J Clin Nutr. 2000 Jun;71(6):1462-9. doi: 10.1093/ajcn/71.6.1462. Am J Clin Nutr. 2000. PMID: 10837286 Clinical Trial.
-
Lipid profile differences during menopause: a review with meta-analysis.Menopause. 2019 Nov;26(11):1327-1333. doi: 10.1097/GME.0000000000001403. Menopause. 2019. PMID: 31567869 Review.
-
[Effects of a 19-norprogesterone derivative, the fourth decade nomegestrol acetate, on lipids].Ann Endocrinol (Paris). 2003 Jun;64(3):216-26. Ann Endocrinol (Paris). 2003. PMID: 12910065 Review. French.
Cited by
-
Variations in lipid levels according to menstrual cycle phase: clinical implications.Clin Lipidol. 2011 Apr 1;6(2):225-234. doi: 10.2217/clp.11.9. Clin Lipidol. 2011. PMID: 21743815 Free PMC article.
-
Monthly haemostatic factor variability in women and men.Eur J Clin Invest. 2014;44(3):309-18. doi: 10.1111/eci.12235. Eur J Clin Invest. 2014. PMID: 24382103 Free PMC article.
-
Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points.J Natl Cancer Inst. 2015 Mar 28;107(5):djv032. doi: 10.1093/jnci/djv032. Print 2015 May. J Natl Cancer Inst. 2015. PMID: 25817193 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous